Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Adient Raises FY2025 Sales Guidance from $13.900B to $14.400B vs $14.014B Est

Author: Benzinga Newsdesk | August 06, 2025 06:54am
Adient (NYSE:ADNT) raises FY2025 sales outlook from $13.900 billion to $14.400 billion vs $14.014 billion estimate.

Posted In: ADNT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist